RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
+17.81%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$5.3B
AUM Growth
+$879M
Cap. Flow
+$279M
Cap. Flow %
5.26%
Top 10 Hldgs %
58.3%
Holding
63
New
4
Increased
10
Reduced
3
Closed
9

Top Buys

1
ASND icon
Ascendis Pharma
ASND
$381M
2
LEGN icon
Legend Biotech
LEGN
$264M
3
AXSM icon
Axsome Therapeutics
AXSM
$71.9M
4
NAMS icon
NewAmsterdam Pharma
NAMS
$59.5M
5
FDMT icon
4D Molecular Therapeutics
FDMT
$55.5M

Top Sells

1
IMGN
Immunogen Inc
IMGN
$368M
2
BLU
BELLUS Health Inc.
BLU
$91M
3
CLDX icon
Celldex Therapeutics
CLDX
$62.4M
4
HLVX icon
HilleVax
HLVX
$29.1M
5
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
$26.7M

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ACRV icon
26
Acrivon Therapeutics
ACRV
$42.2M
$62.3M 1.18%
4,810,508
– –
ICVX
27
DELISTED
Icosavax, Inc. Common Stock
ICVX
$59.2M 1.12%
5,963,565
– –
ITOS
28
DELISTED
iTeos Therapeutics
ITOS
$58.5M 1.1%
4,417,259
– –
FDMT icon
29
4D Molecular Therapeutics
FDMT
$287M
$55.5M 1.05%
+3,069,531
New +$55.5M
MLYS icon
30
Mineralys Therapeutics
MLYS
$1.94B
$54.2M 1.02%
3,178,476
– –
ALPN
31
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$48.2M 0.91%
4,691,178
+3,063
+0.1% +$31.5K
VRDN icon
32
Viridian Therapeutics
VRDN
$1.59B
$47.8M 0.9%
2,007,946
– –
ABOS icon
33
Acumen Pharmaceuticals
ABOS
$82.4M
$47M 0.89%
9,770,773
– –
ACRS icon
34
Aclaris Therapeutics
ACRS
$223M
$45.6M 0.86%
4,398,453
– –
IMGN
35
DELISTED
Immunogen Inc
IMGN
$44M 0.83%
2,329,958
-19,524,000
-89% -$368M
ELVN icon
36
Enliven Therapeutics
ELVN
$1.24B
$43.3M 0.82%
2,122,465
– –
FULC icon
37
Fulcrum Therapeutics
FULC
$353M
$38.3M 0.72%
11,609,704
– –
CLYM
38
Climb Bio, Inc. Common Stock
CLYM
$151M
$36.8M 0.7%
13,150,849
– –
TNYA icon
39
Tenaya Therapeutics
TNYA
$192M
$35.6M 0.67%
6,067,483
– –
ANTX icon
40
AN2 Therapeutics
ANTX
$35.3M
$32.1M 0.61%
3,773,517
– –
PLRX icon
41
Pliant Therapeutics
PLRX
$105M
$31.9M 0.6%
1,762,000
– –
EYPT icon
42
EyePoint Pharmaceuticals
EYPT
$827M
$29.3M 0.55%
3,370,506
– –
SPRY icon
43
ARS Pharmaceuticals
SPRY
$1.08B
$20.2M 0.38%
3,009,678
– –
HOWL icon
44
Werewolf Therapeutics
HOWL
$62.6M
$18.7M 0.35%
6,144,881
– –
DSGN icon
45
Design Therapeutics
DSGN
$339M
$18.7M 0.35%
2,971,231
– –
SLDB icon
46
Solid Biosciences
SLDB
$448M
$18M 0.34%
3,426,286
– –
BDTX icon
47
Black Diamond Therapeutics
BDTX
$164M
$17.8M 0.34%
3,525,754
+935,850
+36% +$4.73M
NKTX icon
48
Nkarta
NKTX
$149M
$17.1M 0.32%
7,805,129
– –
CELC icon
49
Celcuity
CELC
$2.3B
$15.4M 0.29%
1,400,001
– –
IGMS
50
DELISTED
IGM Biosciences
IGMS
$8.65M 0.16%
+937,500
New +$8.65M
1
2
3